First platform trial for ALS hopes to accelerate the development of effective treatments
A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial– the first platform trial for amyotrophic lateral sclerosis (ALS) designed to accelerate the development of effective and breakthrough treatments for people with the illness.
United States Spaulding Rehabilitation Hospital Michellea Detry Lorib Chibnik Sabrina Paganoni Alexanderv Sherman Msc
Source: news-medical.net